Although several new types of synthetic cell-like entities are now available, their structural integration into spatially interlinked prototissues that communicate and display coordinated functions remains a considerable challenge. Here we describe the programmed assembly of synthetic prototissue constructs based on the bio-orthogonal adhesion of a spatially confined binary community of protein-polymer protocells, termed proteinosomes. The thermoresponsive properties of the interlinked proteinosomes are used collectively to generate prototissue spheroids capable of reversible contractions that can be enzymatically modulated and exploited for mechanochemical transduction. Overall, our methodology opens up a route to the fabrication of artificial tissue-like materials capable of collective behaviours, and addresses important emerging challenges in bottom-up synthetic biology and bioinspired engineering.
L
iving tissues and organs comprise spatially interlinked consortia of specialized cells that communicate and display collective behaviours within an integrated three-dimensional (3D) environment. Mimicking these complex living ensembles through the design and construction of artificial tissue-like systems (prototissues) based on the controlled assembly and functional integration of synthetic cell-like entities (protocells) is a major challenge that has important technological implications in bottom-up synthetic biology, bioinspired tissue engineering and microscale engineering of soft machines and devices 1 . Recently, a range of different synthetic protocells based on lipid vesicles [2] [3] [4] [5] , polymersomes [6] [7] [8] [9] , polypeptide capsules 10, 11 , dendrimersomes 12, 13 , inorganic colloidosomes [14] [15] [16] [17] , coacervate microdroplets [18] [19] [20] [21] [22] and semipermeable protein-polymer microcapsules (proteinosomes) [23] [24] [25] [26] [27] have been reported. However, the development of synthetic prototissues based on the assembly of these protocells into higher-order spatial microarchitectures such as spheroidal clusters and sheet-like aggregates that exhibit collective functions due to their structural integration remains a considerable challenge. So far, extended unstructured amorphous aggregates of polymerosomes have been assembled in water by uncontrolled interfacial chemical reactivity [28] [29] [30] [31] , and clusters of limited numbers of lipid-stabilized water-in-oil emulsion droplets produced by microfluidic fabrication [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] or droplet adhesion [35] [36] [37] [38] [39] [40] [41] . In a series of breakthrough studies, Bayley and colleagues have demonstrated the use of 3D printing to spatially organize large numbers of lipid-coated water-in-oil droplets in the form of a rudimentary prototissue capable of membrane protein-mediated electrical communication, macroscopic deformation and light-induced gene expression 42, 43 . In this Article we describe the programmed assembly of spatially integrated prototissue spheroids that comprise a binary community of bio-orthogonally linked proteinosome-based protocells capable of thermoresponsive collective behaviours such as enzymatically modulated reversible contraction, and mechanochemical transduction. These behaviours are based on coordinated interactions between multiple chemically coupled proteinosomes assembled at equilibrium and are therefore considered to be collective in the general sense rather than as a consequence of non-equilibrium (active) behaviour. For this, we synthesize two new types of thermally responsive protein-polymer nanoconjugates with either pendent azide or strained alkyne functionalities, and use the amphiphilic conjugates to prepare two separate populations of bio-orthogonally reactive proteinosomes. Mixed populations of the proteinosomes are spatially confined using a water-in-oil-in-water (w/o/w) Pickering emulsion procedure and then structurally linked in situ via an interfacial strain-promoted alkyne-azide cycloaddition (I-SPAAC) reaction [44] [45] [46] to afford synthetic tissue-like spheroids on removal of the oil phase (see Methods and Supplementary Note 1 for further details). Significantly, individual spheroids exhibit reversible changes in volume due to collective contraction/relaxation of the ligated proteinosomes when transitioned above and below the lower critical solution temperature (LCST) of the thermoresponsive polymer. We show that the contraction/relaxation cycles can be sustained reversibly for tens of cycles at constant frequency and amplitude, and that the process can be switched off during the temperature cycling by internalized enzyme-mediated hydrogelation. Finally, we demonstrate a rudimentary form of prototissue mechanochemical transduction by coupling the reversible contraction/ relaxation behaviour of the spheroids to the down/upregulation of a coordinated enzyme cascade housed specifically within the bioorthogonally linked proteinosomes.
Programmed assembly of protocells into prototissues
Cationized bovine serum albumin (BSA) was covalently conjugated to poly(N-isopropylacrylamide-co-methacrylic acid) (PNIPAM-co-MAA) and the nanoconjugates functionalized with at least 78 azide (N 3 ) or 59 strained alkyne (bicyclo[6.1.0]nonyne (BCN)) functional groups capable of undergoing an I-SPAAC reaction (Fig. 1a,b , Supplementary Figs. 1-11 and Methods). Both bio-orthogonal nanoconjugates exhibited a reversible temperature-dependent change in hydrodynamic diameter between 35 and 45 °C (LCST of ~37 °C; Supplementary Figs. 12 and 13), and were bio-orthogonally reactive when mixed in aqueous solution at room temperature for 15 h (Supplementary Figs. 14 and 15). Given the potential for bioorthogonal chemistry between the nanoconjugates, we anticipated that sustained contact in water between crosslinked proteinosomes prepared with either an N 3 -or BCN-functionalized membrane would lead to similar SPAAC interactions at the microscale level to produce closely packed, covalently linked protocell consortia with spatially interlinked tissue-like structures. We achieved this using a stepwise process based on the encapsulation of 1:1 binary populations of the bio-orthogonal proteinosomes (mean diameter, ~30 μ m; volume, 10 ± 3 pl) within w/o/w Pickering emulsion droplets stabilized by a non-bio-orthogonal membrane of BSA/ PNIPAM-co-MAA nanoconjugates that was stabilized by a crosslinker containing a disulfide bond (NHS-PEG16-DS) (Fig. 1c-e) . Fluorescence microscopy images of the emulsion droplets showed a nested arrangement of water-filled bio-orthogonally reactive proteinosomes that were closely packed, dispersed in an encapsulated oil phase, and housed within a bio-orthogonally non-reactive host proteinosome ( Fig. 1f and Supplementary Fig. 16 ). Significantly, removal of the encapsulated oil triggered bio-orthogonal ligation of the guest proteinosomes to produce membrane-bounded spheroids (mean size, ~70 μ m; volume, 180 ± 80 pl) with a spatially integrated tissue-like structure (Fig. 1g, Supplementary Fig. 17 and Supplementary Video 1). and FITC-tagged alkyne-(green) functionalized crosslinked proteinosomes dispersed in oil and incarcerated within a DyLight405-labelled non-bio-orthogonally crosslinked host proteinosome membrane (blue) (f); individual membrane-bounded prototissue spheroid produced and dye-labelled as in f, and consisting of a spatially interlinked network of closely packed bio-orthogonally ligated crosslinked proteinosomes (red and green) encased in and adhered to a non-bio-orthogonally crosslinked host proteinosome membrane (blue) (g); uncaged spheroid after removal of the outer proteinosome membrane with an intact bio-orthogonally interconnected tissue-like architecture (h). Scale bars in f, g and h, 100, 50 and 50 μ m, respectively. See Supplementary Note 3 for figure legends with full details.
The above observations indicated that high levels of bioorthogonal adhesion over relatively short periods of time (typically within 6-8 h) could be achieved by spatial confinement of the reactive proteinosomes at high packing densities. Crosslinking of the outer non-bio-orthogonal BSA/PNIPAM-co-MAA membrane with NHS-PEG16-DS was critical to prevent disassembly of the caged spheroids before completion of the bio-orthogonal adhesion process ( Supplementary Fig. 18 ). Moreover, to confirm that the internalized proteinosome network was bio-orthogonally ligated, we chemically disassembled the outer membrane to produce uncaged spheroids that exhibited no change in size (~70 μ m; volume, 180 ± 80 pl), shape or structural integrity in water (Fig. 1h,  Supplementary Fig. 19 and Supplementary Video 2). The results indicated that the number of membrane-mediated adhesions points formed at the contact interface between adjacent proteinosomes was sufficient to generate a self-supporting prototissue. In contrast, caged assemblies of non-bio-orthogonal crosslinked proteinosomes became dispersed after chemical disassembly of the outer membrane ( Supplementary Fig. 20) .
The internal structure of the tissue-like spheroids was investigated using fluorescence microscopy to determine the protocell neighbour number (PNN) (Supplementary Fig. 21 ). For a 1:1 binary population of bio-orthogonal proteinosomes, the average PNN was 4 with each protocell in contact with two proteinosomes of the same kind and with two proteinosomes carrying the complementary bio-orthogonal group. Increasing the number ratio between the strained alkyne-and azide-functionalized proteinosomes to 5:1 and 10:1 did not change the average PNN. Under these conditions, most of the protocells were surrounded by BCN-functionalized proteinosomes. In each case, we attributed the low PNN to the relatively high numbers of proteinosomes located at the surface of the spheroids compared with those positioned within the interior of the prototissue clusters.
The above procedures were highly reproducible and could be adapted to increase the size of the tissue-like spheroids and number of bio-orthogonally linked constituent proteinosomes by decreasing the concentration of the non-bio-orthogonal BSA/PNIPAMco-MAA nanoconjugates (Supplementary Figs. 22 and 23 and Supplementary Table 1) . Typically, caged/uncaged spheroids with average volumes ranging from approximately 180 to 900 pl (mean sizes, 70 and 120 μ m, respectively) and consisting of a total number (n) of 20 to 90 interlinked proteinosomes could be prepared. These observations were consistent with previous studies 23 , which showed that decreases in the concentration of the protein-polymer nanoconjugates produced larger proteinosomes.
Reversible contractions in thermoresponsive prototissues
Having established that an I-SPAAC reaction could be successfully used to produce integrated synthetic cell-like masses of caged or uncaged proteinosomes, we investigated whether the thermoresponsive properties associated with the crosslinked BSA/PNIPAM nanoconjugate membrane 23 could be exploited collectively to generate synthetic prototissues capable of sustained contractions (Fig. 2a) . To achieve this, we heated aqueous dispersions containing uncaged tissue-like clusters (n = 10-30) above the LCST of PNIPAM-co-MAA and monitored the temperature-dependent changes in the equilibrium size of the prototissues by fluorescence microscopy. Remarkably, individual spheroids underwent shrinking of up to 37 ± 5 vol% at 47 °C (Fig. 2b) . Onset of the volume contraction occurred at ~37 °C and progressed approximately linearly up to 47 °C. Corresponding experiments with caged prototissue spheroids revealed similar temperature-dependent changes in contractibility ( Supplementary Fig. 24 ), indicating that the collective thermoresponsive behaviour was not dependent on the presence of a non-bio-orthogonally linked outer membrane. In contrast, a volume contraction of only 11 ± 2 vol% was determined at 47 °C for caged assemblies comprising a binary population of closely packed non-bio-orthogonally linked BSA/PNIPAM-co-MAA proteinosomes ( Supplementary Fig. 25 ). Under these conditions the contractile response was analogous to that observed for freely dispersed individual proteinosomes, which showed a membrane transition temperature of ~37 °C associated with shrinking of up to only 10 ± 1 vol% at 47 °C (Fig. 2b) . Significantly, decreasing the temperature from 47 to below 35 °C resulted in expansion of the prototissue and relaxation back to the original size and morphology (Fig. 2b) .
The above results indicate that bio-orthogonal adhesion of the constituent proteinosomes was primarily responsible for the collective deswelling of the prototissue spheroids. This proposal was also consistent with measurements of the contractile properties associated with caged or uncaged prototissue spheroids comprising different numbers (n) of constituent proteinosomes (Fig. 2c) . Increasing n from 5 to 170 was associated with a nonlinear increase in the percentage volume contraction from 30 vol% to a limiting threshold of ~45 vol%, and was independent of whether the prototissue spheroids were enclosed or not in an outer membrane. We attributed the progressive increase in contractibility to a concomitant increase in the number of coupled bio-orthogonal interactions that enabled the void space in the core of the spheroids to be diminished more effectively until the limiting threshold was reached.
Prototissue spheroids exhibited reversible contraction/relaxation behaviour as the temperature was cycled slowly through the LCST of PNIPAM-co-MAA. Typically, each equilibrium cycle required ~10 min. We increased the rate of oscillation under kinetic conditions by heating the surrounding aqueous solution to 45 °C using a nichrome wire connected to a d.c. power generator, followed by use of a water/ice/NaCl bath to lower the temperature back to 35 °C. As a consequence, we were able to produce prototissue spheroids that exhibited collective contractions that could be sustained reversibly at a constant amplitude for at least ten cycles at frequencies of 2.5 oscillations per minute (Fig. 2d) . The spheroids retained their original volume after each contraction/relaxation cycle, and, in general, contracted and relaxed homogeneously and symmetrically during the thermal cycles (Supplementary Video 3) . However, buckling of the bio-orthogonally linked constituent proteinosomes was observed in some of the spheroids (Supplementary Video 4) , possibly due to the size heterogeneity of the constituent proteinosomes.
Given the reversibility of the contraction/relaxation cycles, we determined the expansion force associated with the thermoresponsive behaviour of individual prototissue spheroids using atomic force microscopy (AFM). An individual spheroid was heated to 50 °C, and the contracted assemblage was then trapped between a mica substrate and AFM cantilever ( Fig. 2e and Supplementary Fig. 26 ). On cooling, a rapid increase in the induced radial force up to a value of 62.2 ± 6.5 nN was observed as the prototissue spheroid expanded back to its native state below the LCST (Fig. 2f) . The prototissue spheroid is structurally analogous to a closed-cell foam 47 , although explicit analytic expressions to account for the elastic properties of such a micro-foam with spatially confined cells partitioned by highly permeable nanometre-thick membranes are not currently available. We considered the elastic property of each spheroid to be dominated by elastic bending and stretching of the membranes of the constituent proteinosomes, and assumed that the viscous drag and the incompressibility of water following prototissue volume change were negligible (Supplementary Note 2). We estimated the Young's moduli (E s ) of the relaxed and contracted crosslinked proteinosome membrane as 2.0 and 9.3 kPa, respectively, using the de Gennes scaling term,
, where k B T = 4.11 × 10 −21 J at 298 K, and ξ is the membrane mesh size (or correlation length). The latter was estimated from ξ ∼ 2R s for a Stokes radius R s derived from the molecular weight cutoff determined from studies of the membrane permeability of FITC-dextran (Fig. 4a,c) . Using the Hertzian theory of contact mechanics and the above E s values, we calculated a lower limit of the force exerted on the AFM cantilever as 4-18 nN. This was comparable with the experimentally detected force of 62.2 nN, suggesting that the theoretical model was consistent with the observed thermoresponsive behaviour of the prototissue spheroids. Interestingly, the force exerted by the prototissue spheroid was commensurate with typical forces determined for collective showing direct correlation between the reversible contractibility and temperature ramps imposed on the system. A maximum contraction of ~37 vol% is observed during each temperature cycle. e,f, Prototissue force measurements using AFM: schematic representation (e) of the experiment design showing a contracted prototissue spheroid (blue circle) that is trapped at a temperature above the LCST between a mica surface and calibrated colloidal cantilever. On cooling below the LCST, the prototissue expands back to the native state and the cantilever deflection is quantified. The force exerted by the prototissue was calculated as the product of the cantilever deflection and cantilever spring constant (0.055 N m behaviour in biological systems such as beating cardiomyocyte clusters 48 , migrating endothelial cells 49 and motile bacteria colonies 50 , all of which fall within the range of 1-100 nN.
enzyme-mediated modulation of prototissue contractibility
Although the reversible contraction frequency was determined by external control of the temperature ramp, we sought to internally switch off or modulate the amplitude of the collective behaviour by a process involving the coordinated enzyme-mediated supramolecular assembly of a peptide hydrogel specifically within the prototissue spheroids (Fig. 3a and Supplementary Figs. 27 and 28 ). In the presence of the peptide N-fluorenyl-9-methoxy-carbonyl-D-alanine-D-alanine; Fmoc-Ala-Ala-OH) and in the absence of substrate (maltose) at pH 8.5, reversible oscillatory contractions were observed between 25 and 47 °C for spheroids comprising a 1:1 mixture of bio-orthogonally linked α-glucosidase (AGL)-containing N 3 -BSA/PNIPAM-co-MAA and glucose oxidase (GOx)-containing BCN-BSA/PNIPAM-co-MAA proteinosomes (Fig. 3b,c and Supplementary Fig. 29 ). In contrast, addition of maltose and subsequent hydrogelation of the tissue-like spheroids resulted in progressive dampening of the amplitude and switching off of the temperature-induced reversible contractions (Fig. 3b,c and Supplementary Fig. 30 ). Although a normal contraction of ~40 vol% was determined for the first heating step from 25 and 47 °C, subsequent cooling did not reinstate the native state but resulted in arrested relaxation to produce spheroids that remained partially constricted with volume contractions of ~25%. Subsequent heating/cooling cycles showed that relaxation of the individual spheroids decreased in amplitude after each temperature cycle until the reversible contractibility was eliminated after the fifth cycle to produce a thermally non-responsive prototissue with a constant volume contraction of ~40% (Fig. 3b,c) . Interestingly, restoration of the maximum amplitude and reversible contractibility between 25 and 47 °C was achieved by removing excess maltose and peptide, and raising the pH to 8.5, which disassembled the hydrogel within the spheroids (Fig. 3b,c) . The reversibility could then be switched off again by reinstating the enzyme-mediated re-formation of the peptide hydrogel.
These observations confirmed that curtailment of the spheroid relaxation was dependent on the presence of the peptide hydrogel. Although the precise mechanism responsible for the onset of irreversibility was not elucidated in detail, differential scanning calorimetry (DSC) measurements indicated that the peptide hydrogel was thermally stable at the temperatures used to study amplitude modulations in the contractile prototissue ( Supplementary Fig. 31 ). In addition, lowering the maximum temperature in the thermal cycles from 47 to 40 °C eliminated the irreversible contractibility to produce hydrogelated spheroids capable of undergoing oscillatory transitions exhibiting a constant but reduced amplitude of ~20 vol% ( Supplementary Fig. 32 ). These observations suggested that progressive inhibition in the relaxation of the hydrogelated spheroids was associated with stabilization of high levels of wrinkling of the bio-orthogonally linked proteinosome membranes. One possibility is that localized reconstruction of the peptide nanofilaments around the PNIPAM-co-MAA copolymer chains of the membrane building blocks results in immobilization of the contracted spheroids due to steric hindrance at the molecular level.
Mechanochemical transduction within prototissues
Given the thermoresponsive behaviour of the bio-orthogonally linked proteinosome spheroids, we investigated whether the collective contractile properties could be used to influence the ability of the synthetic prototissues to sense the surrounding chemical environment and perform cooperative internalized enzyme catalysis within proteinosome volumes of ~10 pl. As a step towards this goal, we first investigated whether the collective contractile properties could influence the permeability of the prototissue spheroid. To do this, we incubated the spheroids at 25 or 47 °C in the presence of a series of FITC-labelled dextrans with different molecular weights ranging from 4 to 150 kDa (Fig. 4a,b) , and measured the diffusion of the macromolecules into the prototissue spheroids using optical and fluorescence microscopy. The results indicated that the MWCO associated with the prototissue spheroid was ~80 kDa at 25 °C and 30 kDa at 47 °C (Fig. 4c) . The drastic reduction of ~50 kDa accompanying the transition from the relaxed to the contracted form was also obtained for caged prototissue spheroids. In contrast, analogous experiments using either strained alkyne-or azide-functionalized single proteinosomes showed a MWCO of ~100 kDa, which within experimental error was temperature-independent ( Supplementary  Fig. 33 ). We attributed these differences to the collective mechanical properties of the prototissue spheroids originating from the chemical ligation and spatial integration of the individual proteinosomes into the interlinked assemblages of protocells.
Inspired by the above observations, and as a step towards a rudimentary form of synchronized mechanochemical transduction, we prepared uncaged prototissues (n = 10-30) from a binary population of FITC-labelled BCN-BSA/PNIPAM-co-MAA and unlabelled N 3 -BSA/PNIPAM-co-MAA proteinosomes that were pre-loaded with entrapped GOx or horseradish peroxidase (HRP), respectively. We then perfused the synthetic prototissues in an aqueous solution containing proteinosome-permeable molecular substrates (glucose/Amplex Red or glucose/2,2′ -azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS)) to initiate a spatially coupled GOx/ HRP enzyme cascade reaction within expanded or contracted bioorthogonally linked spheroids (Fig. 4d) . Initially, we used fluorescence microscopy to determine the location of the GOx-containing FITC-labelled BCN-BSA/PNIPAM-co-MAA proteinosomes within individual prototissue spheroids, and to monitor the onset and in situ development of the entrapped enzyme cascade when the spheroids were incubated at 25 °C with a mixture of glucose and Amplex Red (Fig. 4e,f and Supplementary Video 5) . Typically, the onset of red fluorescence due to initial production of resorufin in the HRP-containing N 3 -BSA/PNIPAM-co-MAA proteinosomes occurred within 50 s, followed by leakage into the neighbouring GOx-containing proteinosomes and external environment. In contrast, control experiments involving uncaged spheroids lacking either GOx or HRP showed no increases in fluorescence ( Supplementary  Fig. 34 ) due to the inability of these prototissues to sense glucose in the surrounding environment or synthesize resorufin, respectively.
Having established that molecular substrates can diffuse freely at room temperature into the bio-orthogonally linked matrix of the uncaged prototissue spheroids to access the proteinosome-encapsulated enzymes via passive membrane uptake, we explored the possibility of coupling the temperature-dependent collective contractile properties to the sensing and coordinated catalytic properties of the synthetic tissue-like assemblies. If feasible, such a strategy could provide a step towards a synthetic cell-like tissue exhibiting a rudimentary form of synchronized mechanochemical transduction. As a proof of concept, we monitored the initial rate of reaction for the prototissue-confined GOx/HRP cascade in the presence of glucose and ABTS at a range of temperatures between 25 and 45 °C (Fig. 4g) . Interestingly, whereas increases in the initial reaction rate were observed between 25 and 45 °C for GOx/HRP in free solution or for a dispersed binary population of GOx-containing and HRPcontaining proteinosomes, the collective contractile behaviour of the prototissue spheroids gave rise to an ~53% decrease in the initial reaction rate over the same temperature range. Initially, an increase in the reaction rate was observed when the temperature was raised to 30 °C, but this was followed by progressive decreases in enzyme activity at higher temperatures. Reducing the temperature from 45 to 25 °C indicated that the contractile-dependent changes in enzyme activity were reversible (Fig. 4g ).
Outlook
As a step towards the programmed assembly of synthetic protocells into tissue-like constructs, we use bio-orthogonal chemistry to engineer the membrane reactivity of a spatially confined binary population of proteinosomes. Bio-orthogonal adhesion of the densely packed proteinosomes produces membrane-caged or uncaged prototissue spheroids that are typically 40-100 μ m in size and consist of 10-30 semipermeable protein-polymer microcapsules. The prototissue spheroids are capable of housing proteinosome-encapsulated enzyme cascade reactions, and show enhanced volume contractions compared with caged assemblies of unbound non-bio-orthogonal proteinosomes or individual proteinosomes when heated above 35 °C. We exploit the collective contractibility to produce tissuelike constructs capable of reversible and sustainable contractions that can be enzymatically modulated and exploited for the mechanochemical transduction of a proteinosome-coordinated enzyme cascade. The emergence of the higher-order behaviour arises from collective interactions and coordinated responses that are facilitated by spatial integration of the synthetic protocells within the prototissue spheroids.
From a more general perspective, due to the covalent nature of the inter-proteinosome junctions, the spheroids display high Arrows indicate approximate MWCOs of 80 kDa at 25 °C and 30 kDa at 47 °C, corresponding to the relaxed and contracted states of the spheroids, respectively. d, Scheme representing coupling of the contractile behaviour to a GOx/HRP enzyme cascade reaction in a prototissue spheroid (blue dashed circle) consisting of GOx-containing alkyne-functionalized proteinosomes (green circles) and HRP-containing azide-functionalized proteinosomes (red circles). In the relaxed prototissue (V 1 ), glucose (Glc) and ABTS or Amplex red freely diffuse through the system, and are transformed into d-glucono-1,5-lactone (GDL) and green ABTS •+ or red fluorescent resorufin, respectively. In the contracted form (V 2 ), diffusion of the substrates towards the enzymes is hindered. e, Time-dependent confocal fluorescence microscopy images of a single uncaged prototissue spheroid prepared as described in a in the presence of glucose and Amplex Red at 25 °C. Green fluorescence, GOx-containing FITC-labelled alkyne-functionalized proteinosomes. Red fluorescence, resorufin production. Scale bar, 50 μ m. Numbers shown at t = 0 s show selected areas used for fluorescence intensity measurements (f). f, Timedependent plots of total fluorescence intensity recorded from selected regions of the spheroid shown in e: (1) GOx-containing proteinosomes (green), (2) HRP-containing proteinosomes (red), (3) external aqueous environment (blue). g, Plots of reversible temperature-dependent changes in initial reaction rates for GOx/HRP-mediated cascade reactions undertaken in the presence of glucose (5 mM) and ABTS (0.1 mM) for enzymes in free solution (control, black), a dispersed 1:1 population of non-coupled GOx-containing and HRP-containing proteinosomes (dark yellow) and GOx/HRP-containing prototissue spheroids (blue). See Supplementary Note 3 for figure legends with full details. stability in water (> 6 months), thereby opening up possibilities for building enzymatically active tissue-like structures capable of internalized protocell-protocell communication and sensing of chemical stimuli in the surrounding environment. Significantly, proteinosome-based protocell models exhibiting gene-directed protein synthesis, membrane-gated enzyme activity, selective membrane permeability, membrane-mediated tandem catalysis, protease-mediated disassembly, and hierarchical storage and release behaviour have been demonstrated recently [22] [23] [24] [25] [26] , suggesting that it should be possible to fabricate synthetic prototissues with a wide range of collective functions and behaviours. Our methodology therefore opens up a route from the synthetic construction of individual protocell models to the co-assembly and spatial integration of multi-protocellular structures that combine the specialization of individual protocell types with the collective properties of the ensemble. In general, the rational design and fabrication of prototissues bridges an important gap in bottom-up synthetic biology strategies, and contributes to the development of new bioinspired materials for potential use in areas such as tissue engineering, cellprotocell interactions (drug delivery, signalling, gene regulation) and micro-bioreactor technology.
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Any methods, additional references, Nature Research reporting summaries, source data, statements of data availability and associated accession codes are available at https://doi.org/10.1038/ s41563-018-0183-5. ) and maltose were purchased from Sigma-Aldrich. Acetonitrile, Amplex Red, DyLight405 and Hoechst 33258 were purchased from Thermo Fisher Scientific. Hexanes and glucose was purchased from VWR. N-ethyl-N′- (3-dimethylaminopropyl) carbodiimide hydrochloride (EDAC) from Alfa Aesar, and N-fluorenyl-9-methoxycarbonyl-D-alanine-D-alanine (Fmoc-Ala-Ala-OH) was purchased from Bachem. Dialysis bags with MWCO 1,000 or 12,000-14,000 Da were purchased from Millipore.
Preparation of synthetic tissue-like spheroids. Alkyne-and azide-functionalized proteinosomes in 2-ethyl-1-hexanol (oil) were prepared in two separate 1.75 ml screw-cap vials. To prepare the alkyne-functionalized proteinosomes, 30 μ l of an aqueous solution (8 mg ml ) of NHS-PEG35 in Na 2 CO 3 buffer (pH 8.5, 100 mM) were gently mixed together. 1 ml of 2-ethyl-1-hexanol was gently added on top of the water phase, and the biphasic solution was shaken manually for 10 s to produce a white turbid solution. The same procedure was used to prepare the azide-functionalized proteinosomes in oil except that N 3 -BSA/PNIPAM-co-MAA nanoconjugates were employed as the membrane building block.
Gently shaken oil suspensions of the azide-and alkyne-functionalized proteinosomes were mixed at a 1: 1 ratio, and left to crosslink and co-sediment to the bottom of the vial for at least 2 h. Subsequently, the oil phase was carefully removed and replaced with 1 ml of Na 2 CO 3 buffer (pH 8.5, 100 mM) containing 10 μ l of a 8 mg ml −1 aqueous solution of a non-bio-orthogonal BSA/PNIPAMco-MAA nanoconjugate. The vial was manually shaken for 10 s to produce a white w/o/w emulsion that migrated towards the meniscus. The water phase was carefully removed and replaced with 100 μ l of a 40 mg ml −1 solution of NHS-PEG16-DS in water, and the vial was allowed to stand at room temperature and in the dark for 72 h. The oil layer was then removed by dialysis against water/70% ethanol for 3-4 h, then against water/30% ethanol for 3-4 h, and then 100% water for 18 h, to produce membrane-bounded prototissue spheroids.
To generate uncaged bio-orthogonally ligated proteinosome spheroids, 100 μ l of a 0.5 M solution of sodium azide were added per ml of prototissue solution, and the outer proteinosome membrane cleaved by treatment for 2 h in a solution 50 mM of TCEP (or GSH or DTT) and sodium azide at pH 8.5. The prototissues were then left to sediment overnight, and finally washed three times with clean water using gentle centrifugation.
Contractile behaviour of synthetic tissue-like spheroids. Caged or uncaged prototissue spheroids were introduced into a microscope channel slide (~22 × 3 × 0.3 mm), which was placed on top of a heating plate installed on a fluorescence microscope mobile stage. The temperature was regulated through a thermostat, and allowed to equilibrate for at least 5 min before acquiring the images. The sample temperature was verified through the use of an infrared camera (FLIR E5). Changes in the prototissue volume were determined using ImageJ software. Measurements were repeated three times on different prototissue spheroids. Similar experiments were undertaken on caged or uncaged prototissue spheroids containing different numbers of bio-orthogonally linked proteinosomes, as well as on samples of individual proteinosomes.
To increase the rate of pulsation, a nichrome wire was connected to a d.c. power generator (model 71-10480, 0-30 V, 3 A; Tenma) and placed inside a microscope channel slide along with a sample of the caged or uncaged prototissue spheroids. Subsequently, a K-type thermocouple (EL-USB-2-LCD; Lascar Electronics) was also introduced into the microscope channel slide to monitor the solution temperature in situ and in real time. A contraction was stimulated by supplying current through the nichrome wire (1.500 A, 5.60 V) until the solution temperature reached 45 °C, at which point the d.c. power generator was switched off. Relaxation of the prototissue spheroid was then achieved by rapidly dissipating the heat using a water/ice/NaCl bath, which was placed on top of the microscope slide. The heating/cooling cycle was repeated at least 10 times. Images were captured on video using the fluorescence microscope. 
) were mixed with a solution of the BCN-BSA/PNIPAM-co-MAA or N 3 -BSA/PNIPAM-co-MAA nanoconjugates, respectively. The enzyme-containing Pickering emulsions were mixed at a 1:1 ratio and uncaged prototissue spheroids prepared as described above. Residual enzymes in the surrounding aqueous solution arising from proteinosome fragmentation during sample preparation were removed by gentle centrifugation To monitor the onset and development of the GOx/HRP enzyme cascade within the synthetic prototissue spheroids incubated at 25 °C, a freshly prepared solution of Amplex Red (10 μ l; 2.5 mM) was mounted on a PEGylated glass coverslip, and 40 μ l of an aqueous dispersion of the uncaged GOx/HRP-containing prototissue spheroids was then added. The location of the GOx-containing FITC-labelled BCN-BSA/PNIPAM-co-MAA proteinosomes within individual prototissue spheroids was then imaged by fluorescence microscopy (time t 0 ). Subsequently, a freshly prepared glucose solution (2.5 μ l, 300 mM) was carefully added to the Amplex Red/prototissue dispersion (final glucose and Amplex concentrations; 14 mM and 0.5 mM, respectively), and the enzyme-mediated cascade synthesis of the fluorescent product resorufin was monitored spatially and analytically for 15 min using fluorescence confocal microscopy (λ exc = 530 nm, λ em = 600-670 nm).
Temperature-dependent studies (glucose/ABTS).
Prototissue spheroids containing a 1:1 binary population of bio-orthogonally linked GOx-containing unlabelled BCN-BSA/PNIPAM-co-MAA proteinosomes and crosslinked HRP-containing unlabelled N 3 -BSA/PNIPAM-co-MAA proteinosomes were prepared as above but with increased enzyme concentrations (GOx; 12 μ l; 10 mg ml ). Typically, an aqueous solution of freshly prepared 2,2′ -azino-bis (3-ethylbenzothiazoline-6-sulfonic acid) (ABTS; 30 μ l, 0.6 mM), followed by an aqueous solution of glucose (30 μ l, 30 mM), was added to 120 μ l of an aqueous dispersion of the GOx/HRP-containing uncaged prototissue spheroids to initiate the enzyme cascade reaction. Production of the oxidized green product ((ABTS)
•+ ) was monitored at range of temperatures between 25 and 45 °C by UV-vis spectroscopy using a plate reader (BMG LABTECH CLARIOstar High Performance Monochromator Multi-mode Microplate Reader). Data points were acquired every 0.5 s over a duration of 180 s. The initial enzyme reaction rate was calculated using the following equation: Contractile behaviour in hydrogelled prototissue spheroids. Water-in-oil dispersions of crosslinked GOx-containing FITC-labelled BCN-BSA/PNIPAMco-MAA proteinosomes or crosslinked AGL-containing RITC-labelled N 3 -BSA/ PNIPAM-co-MAA proteinosomes were prepared separately using the above procedures except that aqueous solutions of GOx (10 μ l; 10 mg ml ) were mixed with a solution of the BCN-BSA/PNIPAM-co-MAA or N 3 -BSA/PNIPAM-co-MAA nanoconjugates, respectively. The enzyme-containing Pickering emulsions were mixed at a 1:1 ratio and uncaged prototissue spheroids prepared as described above. Residual enzymes in the surrounding aqueous solution were removed by gentle centrifugation.
To initiate the AGL/GOx-mediated hydrogelation of the prototissue spheroids, an aqueous dispersion of the 1:1 proteinosome mixture (17 μ l) in an Eppendorf tube was diluted with a freshly prepared aqueous solution of Fmoc-Ala-Ala-OH (14.8 μ l; 67.6 mM, pH 8.5) and Hoechst 33258 dye (1 μ l, 1 mM), followed by the addition of maltose (67.2 μ l, 1.5 M) (Fmoc-Ala-Ala-OH, maltose and Hoechst 33258 final concentrations; 10 mM, 1 M and 0.01 mM, respectively). The dispersion was transferred into a microscope channel slide, which was then sealed. Hydrogelation of the prototissue over a period of 6-8 h at 25 °C was monitored spatially and analytically using fluorescence microscopy to determine the increase in blue fluorescence associated with sequestration of Hoechst 33258 within the growing dipeptide nanofilaments of the developing hydrogel. The corresponding decrease in pH associated with AGL/GOx-mediated gluconic acid production was monitored in control experiments undertaken over 24 h in the absence of FmocAla-Ala-OH. Data points were acquired automatically every 10 s.
To study the contractile behaviour of the hydrogelled tissue-like spheroids, individual prototissues were subjected to 6 h of the AGL/GOx reaction, and then placed on top of a heating plate installed on a fluorescence microscope mobile stage. The temperature was regulated through a thermostat, and allowed to equilibrate for at least 5 min before acquiring images of the prototissue at different temperatures. The sample temperature was verified through the use of an infrared camera (FLIR E5). To restore maximum amplitude and reversible contractibility, the irreversibly contracted hydrogelated spheroids were introduced into an Eppendorf tube and centrifuged (1 min at 0.1g, followed by 1 min at 0.4g). The supernatant was then removed and replaced with Na 2 CO 3 buffer (0.1 M, pH 8.5).
DSC measurements were performed on bulk peptide hydrogels using a TA Instruments DSC100 instrument. The hydrogel was prepared by adding to a 1.75 ml glass vial a freshly prepared solution of Fmoc-Ala-Ala-OH in water (148 μ l; 67.6 mM, pH 8.5), a freshly prepared solution of AGL/GOx in water (180 μ l; GOx 5 μ l, 10 mg ml −1 ; AGL 10 μ l, 10 mg ml
), and a freshly prepared solution of maltose in water (672 μ l, 1.5 M). The vial was incubated at room temperature for 18 h.
Characterization. Matrix-assisted laser desorption/ionization-time of flight mass spectrometry (MALDI-TOF MS) was performed on a 4700 Proteomics analyser (Applied Biosystems). The preparation of protein, protein/PNIPAM-co-MAA and PNIPAM-co-MAA samples required three solutions: (1) ), (2) 2 vol % TFA in water, and (3) 1-5 mg ml −1 of protein, polymer or protein-polymer nanoconjugate in water. The three solutions were mixed in a 1:1:1 ratio and spotted on the MALDI plate. Alternatively, polymer samples were prepared by mixing a trans-2-(3-(4-tertbutylphenyl)-2-methyl-2-propenylidene)malononitrile matrix (20 mg ml −1 in THF) with the polymer sample (2-8 mg ml −1 in THF) at a 10:1 (vol/vol) ratio. Gel permeation chromatography (GPC) characterization of PNIPAM-co-MAA was carried out using a Viscotek GPCmax equipped with a UV-vis detector operating at 240 nm, a differential refractometer and a column oven (35 °C H NMR spectra are reported as δ in units of parts per million (ppm) relative to chloroform (δ 7.26, s). The number of protons (n) for a given resonance is indicated as nH, and was based on spectral integration values. 13 C NMR spectra are reported as δ in units of ppm relative to CDCl 3 (δ 77.23, t).
Fourier transform infrared spectra were recorded using a Perkin Elmer Spectrum One spectrophotometer equipped with an attenuated total reflectance sampling accessory. Polymer and protein-polymer nanoconjugate samples were measured directly as solids, and the blank was automatically subtracted from each spectrum.
Circular dichroism spectroscopy was performed on a Jasco J-810/5 spectrometer. Spectra were recorded from 260 to 190 nm at 50 nm min ) were run in a 0.1 cm quartz cuvette cell. Dynamic light scattering and zeta-potential measurements were performed on a ZETASIZER Nano series instrument (Malvern Instruments, UK) using 1 mg ml -1 solutions.
Optical and fluorescence microscopy was performed on a Leica DMI3000 B manual inverted fluorescence microscope at × 20 and × 63 magnification. A heating plate was installed to perform the temperature-dependent measurements on proteinosomes and 3D tissue-like spheroids. Images were analysed using ImageJ software.
Confocal microscopy images were obtained on a Leica SP8 AOBS confocal laser scanning microscope attached to a Leica DM I6000 inverted epifluorescence microscope with ' Adaptive Focus Control' to correct focus drift during time courses. The microscope was equipped with the following lasers: 65 mW Ar (458, 476, 488, 496 and 514 nm lines), 20 mW solid state yellow (561 nm), 2 mW Orange HeNe (594 nm), 10 mW Red He/Ne (633 nm) and a 50 mW 405 nm diode. All measurements were performed in an environmental chamber maintained at 25 °C. Images were analysed using ImageJ software.
Preparation of polymers, derivatized proteins and bio-orthogonal protein/ polymer nanoconjugates. PNIPAM-co-MAA. N-isopropylacrylamide and AIBN were freshly recrystallized from hexane and methanol, respectively. N-isopropylacrylamide (0.900 g; 7.95 mmol), methacrylic acid (50 mg, 0.58 mmol; 6.8 mol/mol %, 5 wt%), AIBN (2.4 mg, 15 μ mol) and mercaptothiazoline-activated reversible addition-fragmentation chain-transfer (RAFT) agent (25 mg, 68 μ mol) 23 were dissolved in 4 ml of acetonitrile in a small round-bottomed flask equipped with a stirrer bar. The solution was purged with argon for 30 min and the flask sealed. Polymerization was carried out at 65 °C for 8 h with stirring at 700 r.p.m. The polymer was isolated by precipitation from 1:1 hexane/Et 2 O (250 ml) as a crystalline light-yellow powder in 96 wt% yield, M n = 13,000 g mol −1 , PDI 1.06 (GPC), 5 wt% in methacrylic acid.
Labelling of BSA with fluorescent dyes. In general, 20.9 mg of BSA was dissolved in 7.74 ml of Na 2 CO 3 buffer (pH 8.5, 100 mM), and 193.5 μ l of a DMSO solution of a fluorescent dye (1.0 mg ml −1 , FITC, RITC or DyLight405-NHS) was added. The conjugation reaction was performed for 5 h at room temperature. The fluorescent dye-conjugated BSA was purified by dialysis, lyophilized, and stored as a solid at − 20 °C.
Cationization of BSA.
In a vial, 18 mg of non-fluorescent or fluorescent dyelabelled BSA was dissolved in 1.8 ml of water. In a separate vial, 180 mg of hexamethylenediamine was dissolved in 1.8 ml of water, and the pH was adjusted to 6.0. The hexamethylenediamine solution was slowly added to the BSA solution under vigorous stirring, and the pH was readjusted to 6.0. The cationization reaction was initiated by adding 9.0 mg of EDAC dissolved in 500 μ l of water. After 2 h, another 9 mg of EDAC dissolved in 500 μ l of water was added. The reaction was left under stirring at room temperature for 18 h. BSA-NH 2 was purified by dialysis, centrifuged (5 min, 3,466g) to remove any precipitate, and then lyophilized and stored as a solid at − 20 °C. On average, this procedure resulted in a 30% level of cationization as determined by MALDI-TOF spectrometry.
BSA/PNIPAM-co-MAA. In a vial, 20 mg of cationized BSA was dissolved in 10 ml of Na 2 CO 3 buffer (pH 8.5, 100 mM). In a separate vial, 20 mg of mercaptothiazoline-activated PNIPAM-co-MAA was dissolved in 10 ml of water. The mercaptothiazoline-activated PNIPAM-co-MAA solution was added dropwise to a stirred solution of cationized BSA, and the conjugation reaction carried out for 18 h at room temperature. BSA-NH 2 /PNIPAM-co-MAA was then isolated by centrifugation using centrifugal filters with 50,000 Da MWCO. The residues were washed four times to remove any unreacted polymer, and the product was lyophilized and stored as a solid at − 20 °C.
Bio-orthogonal BSA/PNIPAM-co-MAA nanoconjugates. In a vial, 10 mg of BSA/ PNIPAM-co-MAA was dissolved in 9.8 ml of water. In a separate vial, 10 mg of BCN-NH 2 (3.1 μ mol) or N 3 -NH 2 (4.6 μ mol) was dissolved in 100 μ l of DMSO. The BCN-NH 2 or N 3 -NH 2 solution was slowly added to the stirred BSA/PNIPAM-co-MAA solution, and the pH adjusted to 6.0. The coupling reaction was initiated by the addition of 5 mg of EDAC (2.6 μ mol) dissolved in 100 μ l of water. After 1 h, the pH was raised to 8.0, and the reaction carried out at room temperature for 18 h. The bio-orthogonal BSA nanoconjugates were purified by dialysis, centrifuged to remove any precipitate, and then lyophilized and stored as a solid at − 20 °C.
Permeability studies for caged and uncaged prototissue spheroids. Experiments were performed by mixing 40 μ l of solutions 0.1 mg ml −1 of FITC-labelled dextran (FITC-Dextran, Sigma-Aldrich) with a molecular weight ranging from 4 to 150 kDa, with 40 μ l of a prototissue spheroid or proteinosome aqueous dispersion. The polymer solution and the prototissue or proteinosome dispersion were preequilibrated either at 25 or 47 °C before mixing. All data are based on normalized fluorescence intensity values determined from fluorescence microscopy images using ImageJ software.
Prototissue force measurements using AFM. The external force induced by the thermoresponsive expansion of individual prototissue spheroids was investigated by AFM. A Multi-mode VIII microscope with Nanoscope V (Bruker) controller was utilized in combination with a fluid cell and Bio-Heater mount. For bulk measurements of the expansion-induced radial force, a micro-cantilever was used with a spring constant of 0.055 N m −1 , as calibrated via thermal tuning. A silica microsphere of radius 7 µ m was attached to the cantilever to produce a colloidal cantilever, and thereby ensure a large contact area between the cantilever and prototissue spheroid and reduce the risk of puncturing the expanding surface. A dispersion of the prototissues (40 μ l) was deposited on freshly cleaved mica before being sealed in the fluid cell. An individual prototissue spheroid was identified optically, heated to 50 °C, and allowed to equilibrate before being trapped between the mica and the microsphere of the colloidal cantilever. The deflection of the cantilever was monitored in real time as the prototissue cooled to 30 °C. The radial force induced by expansion of the spheroid was calculated by the application of Hooke's law (F(x) = kx, where x is the deflection of the cantilever and k is the cantilever spring constant). Measurements were repeated for three heating-cooling cycles on individual prototissue spheroids. Background contributions associated with the deflection measurements were deconvoluted by undertaking force measurements directly at the surface of the mica substrate (control experiments).
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